Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group

Journal of Clinical Epidemiology

Volumn 80, Issue , 2016, Pages 3-7

  Guyatt, Gordon H ^a   Alonso Coello, Pablo ^b   Schünemann, Holger J ^a   Djulbegovic, Benjamin ^c   Nothacker, Monika ^d   Lange, Stefan ^e   Murad, M Hassan ^f   Akl, Elie A ^a,g  

^a MCMASTER UNIVERSITY   (Canada)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d AWMF IMWi   (Germany)

^e INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

^f MAYO CLINIC   (United States)

^g AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; GOOD CLINICAL PRACTICE; HEALTH SERVICE; HUMAN; NOTE; PRIORITY JOURNAL; PRACTICE GUIDELINE;

EVIDENCE-BASED MEDICINE; PRACTICE GUIDELINES AS TOPIC;

EID: 84998799665     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2016.07.006     Document Type: Note

References (24)

1. [1] Guyatt, G., Oxman, A.D., Akl, E.A., Kunz, R., Vist, G., Brozek, J., et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64 (2011), 383–394.
2. [2] Guyatt, G.H., Schunemann, H.J., Djulbegovic, B., Akl, E.A., Guideline panels should not GRADE good practice statements. J Clin Epidemiol 68 (2015), 597–600.
3. [3] Schünemann, H., Oxman, A.D., Guyatt, G.H., Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. 2015, GRADEpro, Hamilton, Ontario Available at http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html Accessed June 30, 2016.
4. [4] Hingorani, A., LaMuraglia, G.M., Henke, P., Meissner, M.H., Loretz, L., Zinszer, K.M., et al. The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg 63:2 Suppl (2016), 3S–21S.
5. [5] Stuenkel, C.A., Davis, S.R., Gompel, A., Lumsden, M.A., Murad, M.H., Pinkerton, J.V., et al. Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100 (2015), 3975–4011.
6. [6] Nieman, L.K., Biller, B.M., Findling, J.W., Murad, M.H., Newell-Price, J., Savage, M.O., et al. Treatment of Cushing's syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100 (2015), 2807–2831.
7. [7] Thornton, P.S., Stanley, C.A., De Leon, D.D., Harris, D., Haymond, M.W., Hussain, K., et al. Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr 167 (2015), 238–245.
8. [8] Speiser, P.W., Azziz, R., Baskin, L.S., Ghizzoni, L., Hensle, T.W., Merke, D.P., et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95 (2010), 4133–4160 Practice Guideline Research Support, Non-U.S. Gov't.
9. [9] WHO guidelines on the Prevention and Treatment of HIV and other Sexually Transmitted Infections for sex workers and their clients in low and middle income countries, 2012, World Health Organization, Geneva Available at http://www.who.int/hiv/pub/guidelines/sex_worker/en/ Accessed June 30, 2016.
10. [10] Hunt, S.A., Abraham, W.T., Chin, M.H., Feldman, A.M., Francis, G.S., Ganiats, T.G., et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (2009), e391–e479 Practice Guideline Review.
11. [11] Furlan, A.D., Reardon, R., Weppler, C., National Opioid Use Guideline Group. Opioids for chronic noncancer pain: a new Canadian practice guideline. CMAJ 182:9 (2010), 923–930.
12. [12] Brito, J.P., Domecq, J.P., Murad, M.H., Guyatt, G.H., Montori, V.M., The Endocrine Society guidelines: when the confidence cart goes before the evidence horse. J Clin Endocrinol Metab 98 (2013), 3246–3252.
13. [13] Alexander, P.E., Gionfriddo, M.R., Li, S.A., Bero, L., Stoltzfus, R.J., Neumann, I., et al. A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance. J Clin Epidemiol 70 (2016), 111–122.
14. [14] Merlin, T., Lehman, S., Hiller, J.E., Ryan, P., The “linked evidence approach” to assess medical tests: a critical analysis. Int J Technol Assess Health Care 29 (2013), 343–350.
15. [15] Schunemann, H.J., Oxman, A.D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G.E., et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336 (2008), 1106–1110.
16. [16] Schunemann, H.J., Mustafa, R., Brozek, J., Diagnostic accuracy and linked evidence–testing the chain. Z Evid Fortbild Qual Gesundhwes 106 (2012), 153–160.
17. [17] Schunemann, H.J., Mustafa, R., Brozek, J., Santesso, N., Alonso-Coello, P., Guyatt, G., et al. Development of the GRADE Evidence to Decision (EtD) frameworks for tests in clinical practice and public health. J Clin Epidemiol, 2016 http://dx.doi.org/10.1016/j.jclinepi.2016.01.032 [Epub ahead of print].
18. [18] Guyatt, G.H., Oxman, A.D., Kunz, R., Woodcock, J., Brozek, J., Helfand, M., et al. GRADE guidelines: 8. Rating the quality of evidence–indirectness. J Clin Epidemiol 64 (2011), 1303–1310.
19. [19] Alexander, P.E., Bero, L., Montori, V.M., Brito, J.P., Stoltzfus, R., Djulbegovic, B., et al. World Health Organization recommendations are often strong based on low confidence in effect estimates. J Clin Epidemiol 67 (2014), 629–634.
20. [20] Alonso-Coello, P., Schunemann, H., Moberg, J., Brignardello-Petersen, R., Akl, E.A., Davoli, M., GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well-informed healthcare choices—1. Introduction. BMJ, 353, 2016, i2016.
21. [21] Andrews, J., Guyatt, G., Oxman, A.D., Alderson, P., Dahm, P., Falck-Ytter, Y., et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 66 (2013), 719–725.
22. [22] Andrews, J.C., Schunemann, H.J., Oxman, A.D., Pottie, K., Meerpohl, J.J., Coello, P.A., et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol 66 (2013), 726–735.
23. [23] WHO. Guideline: WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011, World Health Organization, Geneva Available at http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/9789241548335/en/ Accessed June 30, 2016.
24. [24] Kristiansen, A., Brandt, L., Alonso-Coello, P., Agoritsas, T., Akl, E.A., Conboy, T., et al. Development of a novel, multilayered presentation format for clinical practice guidelines. Chest 147 (2015), 754–763.